Stock Events

Stock Events

Alnylam Pharmaceuticals (A1LN34.SA) Q4 2023 Earnings

2NovConfirmed

Q1 2023

Q2 2023

Q3 2023

Q4 2023

-10.87

-4.37

2.12

8.62

Details

Expected EPS

-6.537828

Actual EPS

8.618046

Surprise EPS

15.16

Surprise Percent

+231.82%

Description

Alnylam Pharmaceuticals (A1LN34.SA) has reported earnings of 8.618046 per share for Q4 2023.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.